The departure of the embattled Bruce Linton from Canopy Growth (TSX:WEED)(NYSE:CGC) on July 3 seems to be hurting the largest cannabis company in the world. The company’s founder was mainly responsible for Canopy’s growth for the past six years. Today, there’s doubt as to whether investors should still buy WEED. Linton left the company with 5.6 million square feet of…
Read More
Aurora Cannabis (TSX:ACB)(NYSE:ACB) may be one of the top stocks in the industry, but that doesn’t mean that it’s the best investment that cannabis investors can make today. Although the company has been showing strong sales growth in recent quarters, it has also incurred losses of around $400 million over just the past two quarters. Now more than ever, cannabis…
Read More
There’s no doubt that the cannabis industry has been an exciting one over the last two years. Canadians who invested in some of the biggest companies have seen in some cases double, or even triple-digit growth. However, this industry has recently slowed down, making many question not only whether there are new opportunities to invest in the cannabis industry, but…
Read More
Summer may be here, but the sun is not shining on marijuana shareholders. After a series of quarterly reports that missed analyst expectations, the sector as a whole began tumbling, with Horizons Medical Marijuana Life Science ETF sliding 29% since March. While the marijuana sector is growing faster than ever, expenses are beginning to spiral out of control, with no…
Read More
Demetrix is engaged as an Emeryville, CA-based biotechnology startup that is focused on the production of cannabinoids. Utilizing microorganisms like baker’s yeast and fermentation, along with advanced biotechnology procedures, Demetrix is able to produce complex ingredients at a very high purity without the excessive costs. The goal is to develop high-quality cannabinoids for the use in pharmaceuticals, supplements, consumer products,…
Read More
OrganiGram Holdings Inc (TSXV:OGI) (NASDAQ:OGI) received some positive press recently. Bruce Linton, former CEO and co-founder of Canopy Growth Corp (TSX:WEED) (NYSE:CGC), picked OrganiGram as one of the top stock picks in the marijuana sector. This led to a bit of a spike in the firm’s share value. As interesting as this nod of approval was, a much more important…
Read More
CannTrust’s regulatory issues, fears that global legal cannabis sales may not expand as fully as envisioned, Canopy Growth’s shock fiscal 2019 results, and an ongoing regulatory crackdown have all taken the shine off the booming legal marijuana industry. They have sparked fears that there are tough times ahead for the once-booming industry, and that this will act as a deterrence…
Read More
It’s been almost a year since marijuana was legalized nationwide, and there’s been pandemonium in the industry. After Health Canada began investigating CannTrust Holdings (TSX:TRST)(NYSE:CTST) for unlicensed cultivation, the small-cap producer suspended all sales, sending shock waves across the entire sector. CannTrust had previously been one of the few consistently profitable weed companies in both net and operating terms, making…
Read More
For reasons that have been covered extensively, CannTrust Holdings (TSX:TRST)(NYSE:CTST) is a shadow of its former self. As of writing, the stock is in the mid-$3 range, and with no clarity from management addressing the investigation, there are no catalysts for recovery back to the $5 level. But chances are, if you’re reading this, you are looking at playing a…
Read More
Canopy Growth is the largest marijuana company in the world by market cap. The firm dominates the Canadian market and racks up revenues that outperform that of any of its peers. Canopy Growth may be one of the better investment options for those looking to profit from the marijuana craze, but one of the firm’s subsidiaries, namely Canopy Rivers (TSXV:RIV),…
Read More